NIDDK Grant Funds Liver Toxicity Pharmacogenetic Study | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institute of Diabetes and Digestive and Kidney Disease has given a $1 million grant to two North Carolina researchers who will use mouse models to discover genetic risk factors that cause some patients to have adverse liver reactions to certain drugs, according to the Hamner Institutes for Health Sciences.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.